Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (1967)	3/9/1999 11:39:00 AM
From: dennis michael patterson	Read Replies (1) \| Respond to of 10280

This action bodes well. What can you say? We bounced right back!

To: BMcV who wrote (1967)	3/9/1999 1:50:00 PM
From: j_fir2	Read Replies (2) \| Respond to of 10280

<<it seems that while Waxman may not like the outcome of this patent situation, that is different than any wrongdoing.>> You know, I think this is vindication of how powerful a strategy SEPR has formulated--it has inspired FTC investigation! It's so good, it has people thinking it might be illegal. Frankly...I work for IP lawyers, and I have a feeling that there really is nothing illegal here, just good old fashioned smarts and business sense. Yes, after this, people/companies will patent their own single isomer versions of the drugs they develop. But for now, and since they didn't before this...GO SEPR! Hope I'm right.